Back
Ultragenyx Pharmaceutical, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
27
RARE
Ultragenyx Pharmaceutical, Inc.
Last Price:
$20.16
Seasonality Move:
-0.92%
7 Day Trial
ALL ACCESS PASS
$
7
-
The current trend is moderately bullish and RARE is experiencing slight selling pressure.
Ultragenyx Pharmaceutical, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 24.18 | Sell |
| 20-day SMA: | 23.94 | Sell |
| 50-day SMA: | 27.76 | Sell |
| 200-day SMA: | 31.43 | Sell |
| 8-day EMA: | 22.07 | Buy |
| 20-day EMA: | 15.27 | Buy |
| 50-day EMA: | 7.98 | Buy |
| 200-day EMA: | 2.3 | Buy |
Ultragenyx Pharmaceutical, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 6.58 | Buy |
| Relative Strength Index (14 RSI): | 41.3 | Sell |
| Chaikin Money Flow: | -371196 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (23.19 - 24.59) | Sell |
| Bollinger Bands (100): | (25.25 - 34.73) | Sell |
Ultragenyx Pharmaceutical, Inc. Technical Analysis
| Jan 30 | Feb 2 | Feb 3 | Feb 4 | Feb 5 | Feb 6 | Feb 9 | Feb 10 | Feb 11 | Feb 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan | Feb | |||||||||
| 30 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Ultragenyx Pharmaceutical, Inc. Stock
Is Ultragenyx Pharmaceutical, Inc. Stock a Buy?
-
Ultragenyx Pharmaceutical, Inc. share price is 23.50 while RARE 8-day simple moving average is 24.18, which is a Sell signal.
-
The stock price of RARE is 23.50 while Ultragenyx Pharmaceutical, Inc. 20-day SMA is 23.94, which makes it a Sell.
-
Ultragenyx Pharmaceutical, Inc. 50-day simple moving average is 27.76 while RARE share price is 23.50, making it a Sell technically.
-
RARE stock price is 23.50 and Ultragenyx Pharmaceutical, Inc. 200-day simple moving average is 31.43, creating a Sell signal.
RARE Technical Analysis vs Fundamental Analysis
Sell
27
Ultragenyx Pharmaceutical, Inc. (RARE)
is a Sell
Is Ultragenyx Pharmaceutical, Inc. a Buy or a Sell?
-
Ultragenyx Pharmaceutical, Inc. stock is rated a SellThe current Ultragenyx Pharmaceutical, Inc. [RARE] share price is $23.50. The Score for RARE is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
Ultragenyx Pharmaceutical, Inc. Stock Info
Market Cap:
2.3B
Price in USD:
23.50
Share Volume:
1.9M
Ultragenyx Pharmaceutical, Inc. 52-Week Range
52-Week High:
46.27
52-Week Low:
18.41
Sell
27
Ultragenyx Pharmaceutical, Inc. (RARE)
is a Sell
Ultragenyx Pharmaceutical, Inc. Share Price Forecast
-
What is the Ultragenyx Pharmaceutical, Inc. stock price today?The Ultragenyx Pharmaceutical, Inc. stock price is 23.50 USD today.
-
Will RARE stock go up or go down?Ultragenyx Pharmaceutical, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Ultragenyx Pharmaceutical, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Ultragenyx Pharmaceutical, Inc. is overvalued.
Is Ultragenyx Pharmaceutical, Inc. Stock a Buy?
-
Ultragenyx Pharmaceutical, Inc. share price is 23.50 while RARE 8-day exponential moving average is 22.07, which is a Buy signal.
-
The stock price of RARE is 23.50 while Ultragenyx Pharmaceutical, Inc. 20-day EMA is 15.27, which makes it a Buy.
-
Ultragenyx Pharmaceutical, Inc. 50-day exponential moving average is 7.98 while RARE share price is 23.50, making it a Buy technically.
-
RARE stock price is 23.50 and Ultragenyx Pharmaceutical, Inc. 200-day simple moving average is 2.30, creating a Buy signal.
Fundamental Analysis of Ultragenyx Pharmaceutical, Inc.
Is Ultragenyx Pharmaceutical, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.25 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.57 per share, and an increase next year of $2.45 per share.
Technical Analysis of Ultragenyx Pharmaceutical, Inc.
Should I short Ultragenyx Pharmaceutical, Inc. stock?
-
RARE Moving Average Covergence Divergence (MACD) indicator is 6.58, suggesting Ultragenyx Pharmaceutical, Inc. is a Buy
-
Ultragenyx Pharmaceutical, Inc. Relative Strength Index (RSI) is 41.3, which suggest Ultragenyx Pharmaceutical, Inc. is oversold
-
The Bollinger Bands (25) for Ultragenyx Pharmaceutical, Inc. is (23.19 - 24.59), which suggest Ultragenyx Pharmaceutical, Inc. is a Sell
-
The Bollinger Bands (100) for Ultragenyx Pharmaceutical, Inc. is (25.25 - 34.73), which suggest Ultragenyx Pharmaceutical, Inc. is a Sell
* Ultragenyx Pharmaceutical, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.